ROSSI, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 2.392
AS - Asia 1.630
NA - Nord America 1.270
SA - Sud America 336
AF - Africa 87
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.768
Nazione #
IT - Italia 1.192
US - Stati Uniti d'America 1.036
CN - Cina 419
GB - Regno Unito 231
DE - Germania 218
IN - India 204
SG - Singapore 174
BR - Brasile 147
JP - Giappone 147
ID - Indonesia 115
MX - Messico 110
SE - Svezia 109
ES - Italia 104
SA - Arabia Saudita 104
CA - Canada 85
FR - Francia 84
HK - Hong Kong 84
RU - Federazione Russa 76
CO - Colombia 70
TR - Turchia 61
PL - Polonia 51
TW - Taiwan 51
NL - Olanda 49
PT - Portogallo 47
TH - Thailandia 46
KR - Corea 44
AU - Australia 43
FI - Finlandia 43
EC - Ecuador 41
IE - Irlanda 34
PH - Filippine 34
VN - Vietnam 33
CL - Cile 32
CH - Svizzera 28
EG - Egitto 26
PE - Perù 25
PK - Pakistan 25
IR - Iran 20
AT - Austria 19
BE - Belgio 18
GR - Grecia 17
RO - Romania 14
LY - Libia 13
ZA - Sudafrica 13
UA - Ucraina 11
AE - Emirati Arabi Uniti 10
NG - Nigeria 10
AR - Argentina 9
DK - Danimarca 9
NZ - Nuova Zelanda 9
CR - Costa Rica 8
PY - Paraguay 8
SV - El Salvador 8
MY - Malesia 7
QA - Qatar 7
GT - Guatemala 6
JO - Giordania 6
NO - Norvegia 6
CZ - Repubblica Ceca 5
KE - Kenya 5
LB - Libano 5
PS - Palestinian Territory 5
BD - Bangladesh 4
IL - Israele 4
IQ - Iraq 4
KW - Kuwait 4
PA - Panama 4
PR - Porto Rico 4
RS - Serbia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
HR - Croazia 3
HU - Ungheria 3
MA - Marocco 3
ME - Montenegro 3
NP - Nepal 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
JE - Jersey 2
LT - Lituania 2
ML - Mali 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
ZM - Zambia 2
AL - Albania 1
CM - Camerun 1
CU - Cuba 1
JM - Giamaica 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 5.767
Città #
Milan 156
Southend 141
Singapore 129
Frankfurt am Main 80
Chandler 78
Riyadh 65
Beijing 50
Rome 47
Jakarta 45
Bogotá 34
Tokyo 34
Dublin 33
Santa Clara 33
Hong Kong 31
Madison 31
Ashburn 29
Central 28
Bengaluru 26
Helsinki 26
Madrid 26
New York 24
São Paulo 24
Turin 24
Princeton 23
Shanghai 23
Santiago 22
Berlin 21
Jeddah 21
Mumbai 21
Chicago 20
Istanbul 20
Taipei 19
Barcelona 18
Lisbon 18
Chennai 17
Delhi 17
Hyderabad 17
Bangkok 16
Cuenca 16
Fairfield 16
Lima 16
London 16
Toronto 16
Warsaw 16
Ann Arbor 15
Boardman 15
Nanjing 15
Atlanta 14
Guwahati 14
Medellín 14
Osaka 14
Wilmington 14
Amsterdam 13
Dong Ket 13
Honcho 13
Mexico City 13
Munich 13
Redwood City 13
Seattle 13
Athens 12
Cairo 12
Florence 12
Paris 12
Tripoli 12
Vienna 12
Boston 11
Ho Chi Minh City 11
Phoenix 11
Sydney 11
Des Moines 10
Genoa 10
Los Angeles 10
Makkah 10
Mountain View 10
San Luis Potosí City 10
Shenyang 10
St Louis 10
Taichung 10
Verona 10
Adelaide 9
Bari 9
Cambridge 9
Guangzhou 9
Naples 9
Porto Alegre 9
Rio de Janeiro 9
Buffalo 8
Chiang Mai 8
Dubai 8
Granada 8
Jacksonville 8
Manila 8
Montreal 8
Nuremberg 8
Pune 8
Quito 8
Rochester 8
Segrate 8
Shenzhen 8
Caruaru 7
Totale 2.179
Nome #
Anti-diabetic drugs and weight loss in patients with type 2 diabetes 2.994
Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome 490
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets 434
Ipertiroidismo da consumo di farmaci contenenti iodocaseina : aspetti clinici e psicologici 238
Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes 220
Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis 194
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 132
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study 120
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response 120
Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity : relationship with abdominal fat deposition 101
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide 98
Improved diastolic function in type 2 diabetes after a six month liraglutide treatment 95
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy 74
Use of Liraglutide in the Real World and Impact at 36 Months on Metabolic Control, Weight, Lipid Profile, Blood Pressure, Heart Rate, and Renal Function 59
Dapagliflozin acutely improvMED/es kidney function in type 2 diabetes mellitus. The PRECARE study 55
Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study 47
One year of Hybrid Closed Loop on peritoneal dialysis: a case report 45
Management of diabetes mellitus in people living with HIV: A single-center experience 42
A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus 42
Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis 38
Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control 34
A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group on Diabetes and Technology 29
Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes 25
Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system 24
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 24
The Impact of Diabetes Mellitus on Cardiovascular Risk Onset in Children and Adolescents 23
A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy 21
Vaccinome landscape in nearly 620 000 patients with diabetes 18
Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and Technology 15
Achieving Good Metabolic Control Without Weight Gain with the Systematic Use of GLP-1-RAs and SGLT-2 Inhibitors in Type 2 Diabetes: A Machine-learning Projection Using Data from Clinical Practice 14
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes 12
Criteria for personalised choice of a continuous glucose monitoring system: An expert opinion 10
Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study 6
Totale 5.893
Categoria #
all - tutte 14.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 2 4 4 4 13 2 1
2020/2021173 0 3 10 10 12 14 9 7 12 17 24 55
2021/2022387 44 37 17 42 39 26 17 23 36 29 14 63
2022/20231.693 45 51 78 124 126 176 180 176 229 128 205 175
2023/20242.177 171 168 198 213 298 152 133 181 139 174 174 176
2024/20251.183 184 233 200 258 231 77 0 0 0 0 0 0
Totale 5.893